Unichem plans new unit at HPIllustrative image – not actual.

Unichem Laboratories has planned to set up a Rs.30 crore active pharmaceutical ingredient (API) plant at Baddi in Himachal Pradesh.

 

The new project, primarily focused on export markets, will be set up adjacent to the company’s existing formulations unit at Baddi which already has in place several international approvals. The new unit will be funded through internal accruals.

 

The plant, which will get income tax exemptions and excise duty benefits from Himachal Pradesh government, is likely to be ready by 2005.

 

Unichem is also in the process of acquiring an US FDA-approved API plant in India. Meanwhile, the company recently modernized its Ghaziabad unit entailing capital expenditure of Rs.33 crore.  The unit, which is undergoing inspection by various international agencies, has been revamped into a multipurpose facility producing the entire range of formulations including tablets, capsules, syrups injectibles.  Unichem’s other units are located at Goa and Roha in Maharashtra.

 

API accounts for around 12 per cent of the company’s turnover, while formulations contribute 82 per cent. The company manufactures a range of APIs including anti-amoebics, anti-hypertensives, anti-depressants, muscle relaxants, anti-asthamatics and de-congestants among others.

 

← All latest storiesBack to top →